Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2025)

Sutro Biopharma (STRO) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.45 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 246.51% to 0.45 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.45 through Dec 2025, up 246.51% year-over-year, with the annual reading at 0.37 for FY2025, 152.6% up from the prior year.
  • Asset Utilization Ratio hit 0.45 in Q4 2025 for Sutro Biopharma, up from 0.4 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q4 2025 to a low of 0.11 in Q3 2023.
  • Historically, Asset Utilization Ratio has averaged 0.23 across 5 years, with a median of 0.18 in 2021.
  • Biggest YoY gain for Asset Utilization Ratio was 246.51% in 2025; the steepest drop was 62.51% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.17 in 2021, then decreased by 3.33% to 0.17 in 2022, then surged by 103.0% to 0.34 in 2023, then crashed by 62.12% to 0.13 in 2024, then skyrocketed by 246.51% to 0.45 in 2025.
  • Business Quant data shows Asset Utilization Ratio for STRO at 0.45 in Q4 2025, 0.4 in Q3 2025, and 0.32 in Q2 2025.